Literature DB >> 9701464

Cytokines, bone remodeling, and estrogen deficiency: a 1998 update.

R L Jilka1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9701464     DOI： 10.1016/s8756-3282(98)00077-5

Source DB:  PubMed          Journal:  Bone        ISSN： 1873-2763            Impact factor:   4.398


× No keyword cloud information.
  38 in total

Review 1.  Skeletal effects of estrogens.

Authors:  G Fiorelli; M L Brandi
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

Review 2.  Hormonal regulation of physiological cell turnover and apoptosis.

Authors:  R D Medh; E B Thompson
Journal:  Cell Tissue Res       Date:  2000-07       Impact factor: 5.249

3.  Response of biochemical markers of bone turnover to estrogen treatment in post-menopausal women: evidence against an early anabolic effect on bone formation.

Authors:  C E Fiore; P Pennisi; F G Tandurella; R Amato; L Giuliano; A Amico; G S Sciacchitano; S Caschetto
Journal:  J Endocrinol Invest       Date:  2001-06       Impact factor: 4.256

Review 4.  Mesenchymal stem cells: lineage, plasticity, and skeletal therapeutic potential.

Authors:  Richard O C Oreffo; Cyrus Cooper; Christopher Mason; Mark Clements
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

5.  Receptor activator of NF-{kappa}B (RANK) cytoplasmic IVVY535-538 motif plays an essential role in tumor necrosis factor-{alpha} (TNF)-mediated osteoclastogenesis.

Authors:  Joel Jules; Zhenqi Shi; Jianzhong Liu; Duorong Xu; Shunqing Wang; Xu Feng
Journal:  J Biol Chem       Date:  2010-09-24       Impact factor: 5.157

Review 6.  Proinflammatory cytokines and osteoporosis.

Authors:  Robert R McLean
Journal:  Curr Osteoporos Rep       Date:  2009-12       Impact factor: 5.096

Review 7.  Selective targeting of RANK signaling pathways as new therapeutic strategies for osteoporosis.

Authors:  Joel Jules; Jason W Ashley; Xu Feng
Journal:  Expert Opin Ther Targets       Date:  2010-09       Impact factor: 6.902

8.  Prepubertal OVX increases IGF-I expression and bone accretion in C57BL/6J mice.

Authors:  Kristen E Govoni; Jon E Wergedal; Robert B Chadwick; Apurva K Srivastava; Subburaman Mohan
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-09-23       Impact factor: 4.310

Review 9.  Metabolic bone disease and parenteral nutrition.

Authors:  Cynthia Hamilton; Douglas L Seidner
Journal:  Curr Gastroenterol Rep       Date:  2004-08

10.  Addition of aerobic exercise to a weight loss program increases BMD, with an associated reduction in inflammation in overweight postmenopausal women.

Authors:  Natalie E Silverman; Barbara J Nicklas; Alice S Ryan
Journal:  Calcif Tissue Int       Date:  2009-03-11       Impact factor: 4.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.